Sailesh Daswani

Sailesh leads the drafting, filing and prosecuting of ARC’s broad patent portfolio, resulting in ARC obtaining several issued patents and recently filing numerous key patents that protect ARC’s products and processes through 2039. Sailesh is knowledgeable regarding nuances in patenting healthcare related inventions including the application of the Hatch-Waxman act, regulatory data protection in Europe and Canada, and patentable subject matter in key jurisdictions. Sailesh also oversees ARC’s trademark portfolio and marking of ARC’s copyright materials.

Sailesh leads ARC’s business development activities, including assisting with ARC’s first out-license deal in Japan, managing ARC’s in-licensed technology, and procuring key deals with suppliers and consultants.

Sailesh possesses over 7 years of experience in polysaccharide research and has co-developed projects with the ARC team on fucoidan extraction, purification, structural modification, and characterization, resulting in substantial contribution of matter to ARC’s recently filed key patents. Sailesh was also engaged in the transfer of ARC’s bench-scale production experiments to pilot scale production processes, resulting in ARC manufacturing its adhesion barrier product at an appreciable scale.

Sailesh holds a BSc (Honors) in Chemistry (his thesis was on polysaccharides) with a minor in commerce, a diploma in data science, a certificate in web development and several certificates in patenting.